Post-Approval Study of PROMUS Element™ in China
NCT01677585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2016
Last updated 2022-02-24
Summary
The purpose of this study is to compile real-world clinical outcomes data for the PROMUS Element™ and PROMUS Element™ Plus Everolimus-Eluting Coronary Stent System (PROMUS Element and PROMUS Element Plus Stent System) in routine clinical practice in China.
Conditions
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Principal Investigators
-
Jian'an Wang, Professor · Second Affliated Hosptial Zhejiang University College of Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2015-12-31
- Completion
- 2019-12-31
Countries
- China
Study Locations
More Related Trials
-
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
NCT00824434 ·Status: COMPLETED ·Phase: PHASE3
-
PROMUS Element Plus US Post-Approval Study
NCT01589978 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization
NCT01342822 ·Status: UNKNOWN
-
PE PREMIER CHINA CLINICAL TRIAL
NCT02230254 ·Status: COMPLETED ·Phase: NA
-
PROMUS Element Japan Small Vessel Trial
NCT01080261 ·Status: COMPLETED ·Phase: PHASE3
-
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
NCT01267734 ·Status: UNKNOWN ·Phase: PHASE4
-
TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)
NCT01242696 ·Status: COMPLETED
-
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT01498692 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
NCT01233453 ·Status: UNKNOWN ·Phase: PHASE4
-
Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions
NCT01186120 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )
NCT01350791 ·Status: COMPLETED
-
PROGRESS-AMS 1.0 Clinical Long Term Follow-Up
NCT01610102 ·Status: COMPLETED
-
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)
NCT01178268 ·Status: COMPLETED ·Phase: PHASE4
-
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan
NCT01086228 ·Status: COMPLETED
-
Everolimus- Versus Biolimus-Eluting Stents in All-Comers
NCT01472705 ·Status: COMPLETED
-
Treatment of Coronary In-Stent Restenosis
NCT01735825 ·Status: COMPLETED ·Phase: NA
-
Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent
NCT02280720 ·Status: COMPLETED ·Phase: PHASE4
-
A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization
NCT01157455 ·Status: UNKNOWN ·Phase: PHASE4
-
A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
NCT03736226 ·Status: ACTIVE_NOT_RECRUITING
-
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
NCT01249027 ·Status: COMPLETED
-
The Promus Element Rewards Study
NCT01794065 ·Status: UNKNOWN
-
China Resolute Integrity 34/38 mm Study
NCT03118531 ·Status: COMPLETED ·Phase: NA
-
Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents
NCT01711931 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis
NCT00598533 ·Status: COMPLETED ·Phase: PHASE4
-
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
NCT00823212 ·Status: COMPLETED ·Phase: PHASE3